UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 5)*
Sunrise Medical, Inc.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $.01 per share
- --------------------------------------------------------------------------------
(Title of Class of Securities)
867910101
- --------------------------------------------------------------------------------
(CUSIP Number)
Richard I. Ellenbogen
EnTrust Capital Inc.
650 Madison Avenue
New York, New York 10022
(212) 888-1040
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
January 22, 1999
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box |_|.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss. 240.13d-7 for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
<TABLE>
<CAPTION>
13D
- -------------------------------------------------- ----------------------------------------------
CUSIP NO. 867910101 PAGE 2 OF 7 PAGES
-------------------- ---------- ---------
- -------------------------------------------------- ----------------------------------------------
- -----------------------------------------------------------------------------------------------------------------------------------
<S> <C> <C>
1
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
Entrust Capital Inc.
(No. 13-3933026)
- -----------------------------------------------------------------------------------------------------------------------------------
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (A) |_|
(B) |_|
- -----------------------------------------------------------------------------------------------------------------------------------
3
SEC USE ONLY
- -----------------------------------------------------------------------------------------------------------------------------------
4
SOURCE OF FUNDS*
OO
- -----------------------------------------------------------------------------------------------------------------------------------
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) |_|
- -----------------------------------------------------------------------------------------------------------------------------------
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -----------------------------------------------------------------------------------------------------------------------------------
7
NUMBER OF SHARES SOLE VOTING POWER
BENEFICIALLY None
---------------------------------------------------------------------------------------------------------------
8
OWNED BY SHARED VOTING POWER
870,940
EACH
---------------------------------------------------------------------------------------------------------------
9
REPORTING SOLE DISPOSITIVE POWER
None
PERSON
---------------------------------------------------------------------------------------------------------------
10
WITH SHARED DISPOSITIVE POWER
1,014,798
- -----------------------------------------------------------------------------------------------------------------------------------
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,014,798
- -----------------------------------------------------------------------------------------------------------------------------------
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- -----------------------------------------------------------------------------------------------------------------------------------
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
4.57%
- -----------------------------------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
IA
- -----------------------------------------------------------------------------------------------------------------------------------
</TABLE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE,
RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS) OF
THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
<PAGE>
EXPLANATORY NOTE
This Amendment No. 5 to Schedule 13D is being filed to indicate that EnTrust
Capital Inc. is no longer the beneficial owner of more than 5% of the Issuer's
equity securities.
ITEM 1. SECURITY AND ISSUER
The title and class of equity security to which this statement on
Schedule 13D relates is the common stock, $.01 par value per share (the "Common
Stock"), of Sunrise Medical, Inc., a Delaware corporation (the "Issuer"). The
address of the Issuer's principal executive office is 2382 Faraday Avenue, Suite
200, Carlsbad, CA 92008.
ITEM 2. IDENTITY AND BACKGROUND
This statement is filed on behalf of EnTrust Capital Inc., a Delaware
Corporation ("EnTrust"), whose principal executive office is located at 650
Madison Avenue, New York, NY 10022.
EnTrust principally engages in the business of an investment adviser
registered under Section 203 of the Investment Advisers Act of 1940, managing
equity and fixed income accounts for clients on a discretionary basis.
The shareholders, directors and principal executive officers of EnTrust
are Michael Horowitz, Mark Fife and Gregg Hymowitz (each, a "Principal"). The
business address of each Principal is 650 Madison Avenue, New York, New York
10022. The principal occupation or each Principal (each of who is a citizen of
the United States) is the business of EnTrust.
During the last five years, neither EnTrust nor any executive officer,
director or shareholder of EnTrust has been (i) convicted in a criminal
proceeding (excluding traffic violations or similar misdemeanors) or (ii) a
party to a civil proceeding of a judicial or administrative body of competent
jurisdiction as a result of which he or it was or is subject to a judgment,
decree or final order enjoining future violations of, or prohibiting or
mandating activities subject to, federal or state securities laws or finding any
violation with respect to such laws.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) As of the close of business on January 22, 1999, and based on the
number of shares of Common Stock reported to be outstanding as of November
6,1998 (i.e., 22,196,483 shares),
EnTrust beneficially owned 1,014,798 shares of Common Stock,
representing approximately 4.57% of the outstanding shares of Common
Stock of the Issuer.
Of the shares of Common Stock beneficially owned by EnTrust,
17,600 shares are for the account of Mark Fife, members of his
immediate family and a foundation controlled by him, 21,450 shares are
for the account of Michael Horowitz and members of his immediate
family, and 5,600 shares are for the account of Gregg Hymowitz and
members of his immediate family.
(b) The responses of EnTrust to (i) Rows (7) through (10) of the cover
page of this statement on Schedule 13D hereof are incorporated herein by
reference.
3
<PAGE>
(c) Attached hereto as Appendix A, is a list of each transaction in the
Common Stock of the Issuer effected by EnTrust Capital Inc. on behalf of clients
since December 31, 1998 (the filing of Amendment No. 4 to Schedule 13D).
(d) Each client of EnTrust whose account holds shares of Common Stock
of the Issuer, has the right to receive or the power to direct the receipt of
dividends from, or proceeds from the sale of, the shares of Common Stock
beneficially owned by EnTrust on his or its behalf. Except with respect to such
clients, EnTrust, to the best of its knowledge, is not aware of any other person
who has the right to receive or the power to direct the receipt of dividends
from, or proceeds from the sale of, the shares of Common Stock of the issuer
beneficially owned by EnTrust.
(e) EnTrust ceased to be the beneficial owner of more than five percent
of the class of the Issuer's securities on January 22, 1999.
4
<PAGE>
SIGNATURE
After reasonable inquiry and to the best of the undersigned's
knowledge and belief, the undersigned certifies that the information set forth
in this statement is true, complete and correct.
Dated: January 26, 1999
EnTrust Capital Inc.
/s/ Richard I. Ellenbogen
----------------------------------------
Name: Richard I. Ellenbogen
Title: Vice President & General Counsel
5
<PAGE>
Appendix A
----------
I. Purchases of the Common Stock of the issuer. Each listed transaction was
effected through brokers or dealers on the New York Stock Exchange, Inc.
<TABLE>
<CAPTION>
Date of Transaction Number of Shares of Common Stock ($) Price Per Share
- ------------------- ----------------------------------- -------------------
<S> <C> <C>
None
II. Sales of the Common Stock of the issuer. Each listed transaction was
effected through brokers or dealers on the New York Stock Exchange, Inc.
<CAPTION>
Date of Transaction Number of Shares of Common Stock ($) Price Per Share
- ------------------- ----------------------------------- -------------------
<S> <C> <C>
1.5.99 650 12.1875
1.5.99 2,100 11.8125
1.7.99 5,600 11.75
1.7.99 650 11.5
1.8.99 64,300 11.8981
1.8.99 1,700 11.75
1.12.99 4,600 11.5
1.14.99 3,200 10.125
1.15.98 3,800 10.0625
1.20.98 27,000 9.9722
1.21.99 5,000 10.0375
1.22.99 1,000 8.0625
1.22.99 896,200 7.8557
Included in the foregoing list of sales are the following transactions
for the accounts of officers, directors and principal shareholders of EnTrust:
<CAPTION>
Account of Michael Horowitz
Date of Transaction Number of Shares of Common Stock ($) Price Per Share
- ------------------- ----------------------------------- -------------------
<S> <C> <C>
1.22.99 550 7.8557
Accounts of Mark Fife (including foundation controlled by him)
<CAPTION>
Date of Transaction Number of Shares of Common Stock ($) Price Per Share
- ------------------- ----------------------------------- -------------------
<S> <C> <C>
1.22.99 11,750 7.8557
6
<PAGE>
Accounts of Gregg Hymowitz (including immediate family members)
<CAPTION>
Date of Transaction Number of Shares of Common Stock ($) Price Per Share
- ------------------- ----------------------------------- -------------------
<S> <C> <C>
1.8.99 12,000 11.8981
1.20.99 4,000 9.9722
1.22.99 10,800 7.8557
</TABLE>
III. An additional 16,850 Shares are held in accounts over which EnTrust no
longer has any beneficial interest.
7
